Evaluate AbbVie Inc. vs. Pfizer Inc. amidst tariff disputes and drug pricing policies. Click for our comparison of ABBV and ...

So, is Pfizer's 7.63% dividend yield worth the effort? If I base my decision solely on a first level analysis of its past, I would say NO. Yet, investment is always about the future, not the past ...

Be aware that Pfizer is showing 3 possible red flags in our investment analysis and 2 of those ... 27 US stocks that are forecast to pay a dividend yield of over 6% next year.

Pfizer recently made headlines with a strategic collaboration with Guardant Health, aimed at enhancing its oncology portfolio through advanced liquid biopsy technology. Simultaneously, the company ...

While its dividend yield remains attractive at current price levels, Pfizer’s near-term growth ... Twitter @JesseCohenInv for more stock market analysis and insight.

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 6 undervalued stocks in the Pharmaceuticals industry for Tuesday, May 13, 2025. Let’s take ...

Learn more about whether BioCryst Pharmaceuticals, Inc. or Zai Lab Limited is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

With limited near-term catalysts to offset these pressures, Pfizer’s stock could face further selling pressure post-earnings. While its dividend yield remains attractive at current price levels, ...

But when a dividend yield reaches ultrahigh levels, investors can feel a heightened level of uncertainty. Wondering if Pfizer ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to ...